PROCEPT BioRobotics Corporation

Healthcare

NASDAQ:PRCT · NASDAQ Global Market

Market Cap $1.19B Beta 0.85 P/E (TTM) -11.6

$21.72 +0.89%

+$0.19 today

52W Low $19.35High $62.17

Vol 1.69M · Avg 1.46M

EPS (TTM) -$1.81Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-63.02%

Period High

$60.06

Period Low

$20.91

Latest

$21.72

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Twist Bioscience Corporation

NASDAQ:TWST

$5.35B

Edgewise Therapeutics, Inc.

NASDAQ:EWTX

$3.86B

Guardian Pharmacy Services, Inc.

NYSE:GRDN

$2.75B

Clover Health Investments, Corp.

NASDAQ:CLOV

$2.57B

Mesoblast Limited

NASDAQ:MESO

$1.84B

Inspire Medical Systems, Inc.

NYSE:INSP

$1.20B

Artivion, Inc.

NYSE:AORT

$1.02B

QuidelOrtho Corporation

NASDAQ:QDEL

$903.58M

SS Innovations International, Inc.

NASDAQ:SSII

$685.45M

BGM Group Ltd.

NASDAQ:BGM

$73.33M

What is the latest PRCT filing?

The latest filing shown is 4 dated Jun 10, 2026.

How many recent filings does PRCT have?

Intrinsic Alpha currently shows 20 recent filings for PRCT.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.